Form 4 for CTMX CytomX Therapeutics, Inc.
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-18 · accession 0001610717-25-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | 2025-03-18 | CTMX | Chu Yu-Waye | Chief Medical Off | S - Sale | $0.6 | -4,025 | 135.7K | -3% | -$2,415 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | S | D | 4,025 | $0.6 | 135,725 | D | — | — | (F2) Includes 131,000 RSUs. |